Abdullah KMA (2016) The effect of immunstimulant drugs used together with fmd vaccine on immunoglobulins in sheep. (Phd thesis). Yüzüncü Yıl Univ., Graduate School of Health Sciences, Dep. of Internal Medicine: 49.

Akdoğan M, Yöntem M (2018) Cytokines. Online Turkish Journal of Health Sciences 3: 36-45.

Anziliero D, Weiblen R, Kreutz L, Spilki F, Flores E (2014) Inactivated Parapoxvirus ovis induces a transient increase in the expression of proinflammatory, Th1-related, and autoregulatory cytokines in mice. Braz J Med Biol Res 47: 110-118.

Arzt J, Juleff N, Zhang Z, Rodriguez L (2011) The pathogenesis of foot‐and‐mouth disease I: viral pathways in cattle. Transbound Emerg Dis 58: 291-304.

Avci O, Bulut O, Dik I (2016) Effects of inactive parapoxvirus ovis on cytokine levels in rats. J Vet Med Sci 78: 129-131.

Bent R, Moll L, Grabbe S, Bros M (2018) Interleukin-1 beta – a friend or foe in malignancies? Int J Mol Sci 19: 2155.

Büttner M, Czerny C-P, Lehner K-H, Wertz K (1995) Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs. Vet Immunol Immunopathol 46: 237-250.

Camcıoğlu Y, Aytaç E (2007) Immunopathogenesis of sepsis. Turkish J. Intensive Care 5: 81-85.

Carnet F, Paillot R, Fortier C, Hue E S, Briot L, de Geoffroy F, Vidalain P-O, Pronost S (2022) Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination. Vaccines 10: 2139.

Diaz-San Segundo F, Medina G N, Stenfeldt C, Arzt J, de Los Santos T (2017) Foot-and-mouth disease vaccines. Vet. Microbiol 206: 102-112.

Doel T (2003) FMD vaccines. Virus Res 91: 81-99.

El-Fadeel M, Mohamed MM, Khafagy HA, Kotb EE, El-Hawary RI (2019) Immunomodulating effect of zylexis on the immune response of cattle vaccinated with (Pneumo-4) vaccine. Int J Vet Sci 8(4): 380-384.

Erbasan S, Mamak N (2023) Investigation of the immunomodulatory effect of inactive parapoxvirus (iPPVO) on infectious bovine rhinotracheitis (IBR) vaccine in cattle. Medit Vet J 8: 183-189.

Friebe A, Siegling A, Friederichs S, Volk H-D, Weber O (2004) Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J Virol 78: 9400-9411.

Grubman M J, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17: 465-493.

Gruys E, Toussaint M, Niewold T, Koopmans S (2005) Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci 6: 1045-1056.

Guo P, Li R, Piao T H, Wang C L, Wu X L, Cai H Y (2022) Pathological mechanism and targeted drugs of COPD. Int J Chron Obstruct Pulmon Dis: 1565-1575.

Haig D M (1998) Poxvirus interference with the host cytokine response. Vet Immunol 63: 149-156.

Ibrahim M, Warda F F, Nermeen G S, Abdel-Baky M, Kalad M A (2017) Effect of Inactivated Sheep Pox Vaccine and Parapox Ovis Virus as Immunomodulators on Response of Equines to Inactivated Herpes Vaccine. J Egypt Vet Med Assoc 77: 61-72.

Janeway C, Travers P, Walport M, Shlomchik M J (2001) The immune system in health and disease Immunobiology 5. Garland Pub. New York, USA 20.05.2025 https://www.ncbi.nlm.nih.gov/books/NBK27162/

Kart A, Uzlu E, Karapehlivan M, Öğün M, Merhan O (2010) Effect of Immunomodulator Zylexis on Blood Glutathione, Malondialdehyde, Nitric Oxide, Total and Lipid Bound Sialic Acids Levels in Calves. Vet Sci Pract 5: 43-48.

Knight-Jones T J, Rushton J (2013) The economic impacts of foot and mouth disease–What are they, how big are they and where do they occur? Prev Vet Med 112: 161-173.

Koj A (1998) Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. Gen Pharmacol 31: 9-18.

Megha K, Mohanan P (2021) Role of immunoglobulin and antibodies in disease management. Int J Biol Macromol 169: 28-38.

Nowatzky J, Knorr A, Hirth‐Dietrich C, Siegling A, Volk HD, Limmer A, Knolle P, Weber O (2013) Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. Hepatol Res 43: 535-546.

Ons E, Van Brussel L, Lane S, King V, Cullinane A, Kenna R, Lyons P, Hammond T-A, Salt J, Raue R (2014) Efficacy of a Parapoxvirus ovis-based immunomodulator against equine herpesvirus type 1 and Streptococcus equi equi infections in horses. Vet Microbiol 173: 232-240.

Rashıd B M, Yüksek N (2019) The effects of immunostimulants (zinc, levamisole, vitamin AD3E) use together with enterotoxemia vaccine on immunoglobulins in sheep. Turkish J Vet Res 3: 57-65.

Rziha H-J, Henkel M, Cottone R, Meyer M, Dehio C, Büttner M (1999) Parapoxviruses: potential alternative vectors for directing the immune response in permissive and non-permissive hosts. Journal of biotechnology 73: 235-242.

Schütze N, Raue R, Büttner M, Alber G (2009) Inactivated parapoxvirus ovis activates canine blood phagocytes and T lymphocytes. Vet Microbiol 137: 260-267.

Smith R E, Strieter R M, Phan S H, Lukacs N, Kunkel S L (1998) TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J Leukoc Biol 64: 528-536.

Tizard I R (2017) Veterinary Immunology. 10: 480-482. Elsevier Health Sciences 032352348X 20.05.2025 https: //books.google.com.tr/books?hl=tr&lr=&id=JuM2DwAAQBA
J&oi=fnd&pg=PP1&dq=Veterinary+Immunology-E-Book: +Veterinary+Immunology-E-Book+2017&ots=ZIfAECT
tEq&sig=tXc2BcA7zQTEu4c6-q8P-bgm4pk&redir_esc
=y#v=onepage&q=Veterinary%20Immunology-E-Book
%3A%20Veterinary%20Immunology-E-Book%202017
&f=false

Traeder W, Brune A, Rehagen M (2005) Protective effect of the paramunity inducer Parapoxvirus ovis (Zylexis) in kittens experimentally infected with Calicivirus (strain FCV-KS 20). Prakt Tierarzt 86: 230-238.

Ülgenalp O, Koç B T, Oğuzoğlu T Ç (2018) A Review on Parapoxviruses Observed in Ruminants: History, Epidemiology, Molecular Characterization, Pathogenesis, Clinical Findings, Immunotherapy and Use as a Vector in Recombinant Vaccines. Anim Health Prod Hyg 7: 551-557.

Van Reeth K, Nauwynck H, Pensaert M (1998) Bronchoalveolar interferon-α, tumor necrosis factor-α, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans? J Infect Dis 177: 1076-1079.

Wang R, Wang Y, Liu F, Luo S (2019) Orf virus: A promising new therapeutic agent. Rev Med Virol 29: e2013.

Weber O, Siegling A, Friebe A, Limmer A, Schlapp T, Knolle P, Mercer A, Schaller H, Volk H-D (2003) Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J Gen Virol 84: 1843-1852.

Wojno E D T, Hunter C A, Stumhofer J S (2019) The immunobiology of the interleukin-12 family: room for discovery. Immunity 50: 851-870.

Wu Y, Zhang Z, Chen L, Sun S (2024) Immunoglobulin G glycosylation and its alterations in aging-related diseases: IgG glycosylation with aging-related diseases. Acta Biochim Biophys Sin 56: 1221.

Yılmaz N, Akgül Y (2014) Immunglobulins and Septicemia. Uludag Univ. J. Vet. Fac 33: 33-42.

Zhuan B, Yu Y, Yang Z, Zhao X, Li P (2017) Mechanisms of oxidative stress effects of the NADPH oxidase-ROS-NF-κB transduction pathway and VPO1 on patients with chronic obstructive pulmonary disease combined with pulmonary hypertension. Eur Rev Med Pharmacol Sci 21: 3459-3464.